Literature DB >> 4836193

Influence of hypophysectomy and starvation on blood glucose levels in the newt, Notophthalmus viridescens.

T G Connelly, A M Goldstein, T Yamada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4836193     DOI： 10.1002/jez.1401880313

Source DB:  PubMed          Journal:  J Exp Zool        ISSN： 0022-104X


× No keyword cloud information.
  13 in total

Review 1.  Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology.

Authors:  Nicolas A Giraldo; J David Peske; Catherine Sautès-Fridman; Wolf H Fridman
Journal:  Virchows Arch       Date:  2019-01-10       Impact factor: 4.064

2.  Time-dependent population PK models of single-agent atezolizumab in patients with cancer.

Authors:  Mathilde Marchand; Rong Zhang; Phyllis Chan; Valerie Quarmby; Marcus Ballinger; Nitzan Sternheim; Benjamin Wu; Jin Y Jin; René Bruno
Journal:  Cancer Chemother Pharmacol       Date:  2021-04-27       Impact factor: 3.333

Review 3.  Optimizing the Combination of Immunotherapy and Trans-Arterial Locoregional Therapy for Stages B and C Hepatocellular Cancer.

Authors:  Matthew R Woeste; Anne E Geller; Robert C G Martin; Hiram C Polk
Journal:  Ann Surg Oncol       Date:  2021-01-03       Impact factor: 5.344

4.  PD1/PDL1 expression is associated with increased TIM3 expression and tumor-infiltrating T lymphocytes in fibroblastic tumors.

Authors:  H Chen; H Liu; J Ai; X Du; Y Sun; S Xiao
Journal:  Clin Transl Oncol       Date:  2021-11-06       Impact factor: 3.405

5.  Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.

Authors:  Lin Sun; Luwen Mu; Jing Zhou; Wenjie Tang; Linqi Zhang; Sidong Xie; Jingbiao Chen; Jin Wang
Journal:  Cancer Immunol Immunother       Date:  2021-05-16       Impact factor: 6.968

6.  High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer.

Authors:  Soomin Ahn; Jong-Chan Lee; Dong Woo Shin; Jaihwan Kim; Jin-Hyeok Hwang
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

Review 7.  Clinical significance of checkpoint regulator "Programmed death ligand-1 (PD-L1)" expression in meningioma: review of the current status.

Authors:  Shirin Karimi; Sheila Mansouri; Farshad Nassiri; Severa Bunda; Olivia Singh; Priscilla K Brastianos; Ian F Dunn; Gelareh Zadeh
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

Review 8.  The emerging role of epigenetic therapeutics in immuno-oncology.

Authors:  Michael J Topper; Michelle Vaz; Kristen A Marrone; Julie R Brahmer; Stephen B Baylin
Journal:  Nat Rev Clin Oncol       Date:  2019-09-23       Impact factor: 66.675

Review 9.  Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer.

Authors:  Roger Li; Jingsong Zhang; Scott M Gilbert; José Conejo-Garcia; James J Mulé
Journal:  Nat Rev Urol       Date:  2021-06-28       Impact factor: 14.432

Review 10.  Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.

Authors:  Michael J Grant; Roy S Herbst; Sarah B Goldberg
Journal:  Nat Rev Clin Oncol       Date:  2021-06-24       Impact factor: 66.675
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.